10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001493152-23-041294`
Period End Date	20230930
Filing Date	20231114
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 68 Cash Flow Statement 68 Stockholders Equity 29

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, stated value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, stated value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$27.05M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$7.14M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$7.17M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableNetCurrent`	$1.68M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableNetCurrent`	$48.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$455.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$263.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	48.80M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$22.74M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	48.08M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$36.32M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$136.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.08M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$195.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.80M	shares	Point-in-time
Unvested stock awards	`SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares`	133,333.00	shares	Point-in-time
Unvested stock awards	`SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares`	561,104.00	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$829.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$727.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.15M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.94M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.10M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.20M	USD	Point-in-time
Total assets	`Assets`	$27.86M	USD	Point-in-time
Total assets	`Assets`	$40.49M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.79M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$377.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.72M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$806.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$207.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$178.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.72M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.36M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$543.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$659.00K	USD	Point-in-time
Commitments and contingencies (Notes 12 and 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 12 and 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred Stock, $0.01 par value, 5,000,000 authorized shares, inclusive of the following:	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $0.01 par value, 5,000,000 authorized shares, inclusive of the following:	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 48,797,450 and 48,084,287 (including 133,333 and 561,104 of unvested stock awards) as of September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$48.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 48,797,450 and 48,084,287 (including 133,333 and 561,104 of unvested stock awards) as of September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$48.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$418.27M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$418.80M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-396.93M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-380.55M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$48.78M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$30.14M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$42.70M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$38.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$56.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$22.60M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$40.49M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$27.86M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$85.00K	USD	3 Qtrs
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$137.00K	USD	3 Qtrs
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$46.00K	USD	1 Quarter
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$21.00K	USD	1 Quarter
Total Revenues	`Revenues`	$137.00K	USD	3 Qtrs
Total Revenues	`Revenues`	$46.00K	USD	1 Quarter
Total Revenues	`Revenues`	$21.00K	USD	1 Quarter
Total Revenues	`Revenues`	$85.00K	USD	3 Qtrs
Production costs	`ManufacturingCosts`	$30.00K	USD	3 Qtrs
Production costs	`ManufacturingCosts`	-	USD	3 Qtrs
Production costs	`ManufacturingCosts`	$30.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.73M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$7.74M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.37M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.88M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.17M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.44M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$9.57M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$10.28M	USD	3 Qtrs
Total Costs and Expenses	`CostsAndExpenses`	$14.45M	USD	3 Qtrs
Total Costs and Expenses	`CostsAndExpenses`	$6.54M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$18.05M	USD	3 Qtrs
Total Costs and Expenses	`CostsAndExpenses`	$8.20M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-8.16M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-17.91M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-14.37M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-6.52M	USD	1 Quarter
Loss on investments	`GainLossOnInvestments`	$-310.00K	USD	1 Quarter
Loss on investments	`GainLossOnInvestments`	$-1.77M	USD	3 Qtrs
Loss on investments	`GainLossOnInvestments`	$-365.00K	USD	1 Quarter
Loss on investments	`GainLossOnInvestments`	$-201.00K	USD	3 Qtrs
Interest and other income	`OtherNonoperatingIncomeExpense`	$172.00K	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$811.00K	USD	3 Qtrs
Interest and other income	`OtherNonoperatingIncomeExpense`	$294.00K	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$296.00K	USD	3 Qtrs
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$16.00K	USD	3 Qtrs
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$39.00K	USD	1 Quarter
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-35.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	1 Quarter
Gain on sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-900.00K	USD	3 Qtrs
Gain on sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-318.00K	USD	1 Quarter
Gain on sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-749.00K	USD	3 Qtrs
Gain on sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-328.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-6.38M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-16.39M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-7.82M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-15.06M	USD	3 Qtrs
Basic loss per share	`EarningsPerShareBasic`	$-0.16	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-0.34	USD	3 Qtrs
Basic loss per share	`EarningsPerShareBasic`	$-0.13	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-0.31	USD	3 Qtrs
Diluted loss per share	`EarningsPerShareDiluted`	$-0.34	USD	3 Qtrs
Diluted loss per share	`EarningsPerShareDiluted`	$-0.31	USD	3 Qtrs
Diluted loss per share	`EarningsPerShareDiluted`	$-0.13	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-0.16	USD	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesIssuedBasic`	48.08M	shares	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesIssuedBasic`	48.04M	shares	3 Qtrs
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesIssuedBasic`	48.48M	shares	3 Qtrs
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesIssuedBasic`	48.64M	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.04M	shares	3 Qtrs
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.48M	shares	3 Qtrs
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.08M	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.64M	shares	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-6.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.39M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-7.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.06M	USD	3 Qtrs
Depreciation of property and equipment	`Depreciation`	$29.00K	USD	3 Qtrs
Depreciation of property and equipment	`Depreciation`	$30.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-35.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	1 Quarter
Abandonment of patent and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	$14.00K	USD	3 Qtrs
Abandonment of patent and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	-	USD	3 Qtrs
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$150.00K	USD	3 Qtrs
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$57.00K	USD	3 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$-717.00K	USD	3 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$151.00K	USD	3 Qtrs
Gain on sale of income tax operating losses	`LossGainFromSaleOfIncomeTaxOperatingLosses`	$749.00K	USD	3 Qtrs
Gain on sale of income tax operating losses	`LossGainFromSaleOfIncomeTaxOperatingLosses`	$900.00K	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$182.00K	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$792.00K	USD	3 Qtrs
Loss on sale of investments	`MarketableSecuritiesUnrealizedGainLoss`	$-1.77M	USD	3 Qtrs
Loss on sale of investments	`MarketableSecuritiesUnrealizedGainLoss`	$-201.00K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$9.00K	USD	3 Qtrs
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	$-1.68M	USD	3 Qtrs
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	$-1.64M	USD	3 Qtrs
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-192.00K	USD	3 Qtrs
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$500.00K	USD	3 Qtrs
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$717.00K	USD	3 Qtrs
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-136.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$73.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.41M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$758.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.33M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$915.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-11.51M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.04M	USD	3 Qtrs
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$9.08M	USD	3 Qtrs
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$924.00K	USD	3 Qtrs
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$1.66M	USD	3 Qtrs
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$1.16M	USD	3 Qtrs
(Purchase of) Proceeds from sale of property and equipment	`ProceedsFromPaymentsToPurchaseOfPropertyAndEquipment`	$300.00K	USD	3 Qtrs
(Purchase of) Proceeds from sale of property and equipment	`ProceedsFromPaymentsToPurchaseOfPropertyAndEquipment`	$-10.00K	USD	3 Qtrs
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$377.00K	USD	3 Qtrs
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$96.00K	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$7.62M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-618.00K	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$338.00K	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$80.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$338.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$80.00K	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.33M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-11.79M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.26M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.76M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.26M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.76M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Operating lease liability arising from obtaining right of use asset	`OperatingLeaseLiabilityArisingFromObtainingRightOfUseAsset`	$717.00K	USD	3 Qtrs
Operating lease liability arising from obtaining right of use asset	`OperatingLeaseLiabilityArisingFromObtainingRightOfUseAsset`	$49.00K	USD	3 Qtrs
Unrealized loss on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$-1.17M	USD	3 Qtrs
Unrealized loss on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$-71.00K	USD	3 Qtrs
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$6.00K	USD	3 Qtrs
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$2.00K	USD	3 Qtrs

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$48.78M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$30.14M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$42.70M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$38.47M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$56.88M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$22.60M	USD	Point-in-time
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$338.00K	USD	3 Qtrs
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$80.00K	USD	3 Qtrs
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$25.00K	USD	1 Quarter
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$233.00K	USD	1 Quarter
Common stock issuance, net of costs, shares	`StockIssuedDuringPeriodSharesNewIssues`	327,055.00	shares	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$50.00K	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$275.00K	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$792.00K	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$182.00K	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-7.82M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-16.39M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-15.06M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-6.38M	USD	1 Quarter
Cashless warrant conversion	`CashlessWarrantConversion`	-	USD	3 Qtrs
Cashless warrant conversion	`CashlessWarrantConversion`	-	USD	1 Quarter
Series B preferred shares converted to common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	3 Qtrs
Series B preferred shares converted to common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	3 Qtrs
Ending balance, value	`StockholdersEquity`	$48.78M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$30.14M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$42.70M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$38.47M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$56.88M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$22.60M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.